| 8.9 0.04 (0.45%) | 11-29 13:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.64 | 1-year : | 13.6 |
| Resists | First : | 9.97 | Second : | 11.64 |
| Pivot price | 8.96 |
|||
| Supports | First : | 7.55 | Second : | 6.07 |
| MAs | MA(5) : | 9.03  |
MA(20) : | 8.39 |
| MA(100) : | 6.91 |
MA(250) : | 7.89 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 63.4 |
D(3) : | 71.1 |
| RSI | RSI(14): 60 |
|||
| 52-week | High : | 10.98 | Low : | 5.73 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ INFU ] has closed above bottom band by 38.9%. Bollinger Bands are 5.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.09 - 9.14 | 9.14 - 9.18 |
| Low: | 8.68 - 8.75 | 8.75 - 8.81 |
| Close: | 8.77 - 8.87 | 8.87 - 8.95 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Wed, 27 Nov 2024
CEO Richard Dilorio Sells 40,000 Shares of InfuSystems Holdings Inc - GuruFocus.com
Wed, 27 Nov 2024
InfuSystem CEO Richard DiIorio sells $364,465 in stock - Investing.com
Fri, 22 Nov 2024
InfuSystem to Present at Sidoti Investor Conference - Nasdaq
Fri, 22 Nov 2024
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 - Business Wire
Fri, 22 Nov 2024
InfuSystem Holdings to Present at Sidoti Small Cap Conference on Dec 4 | INFU Stock News - StockTitan
Tue, 19 Nov 2024
INFU - InfuSystem Holdings, Inc. Latest Stock News & Market Updates - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 21 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 6.1 (%) |
| Held by Institutions | 81.1 (%) |
| Shares Short | 170 (K) |
| Shares Short P.Month | 160 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.5 |
| Profit Margin | 0.2 % |
| Operating Margin | 5.5 % |
| Return on Assets (ttm) | 2.3 % |
| Return on Equity (ttm) | 0.7 % |
| Qtrly Rev. Growth | 6.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 6.06 |
| EBITDA (p.s.) | 0.75 |
| Qtrly Earnings Growth | 50 % |
| Operating Cash Flow | 12 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | 880 |
| PEG Ratio | 2.7 |
| Price to Book value | 3.5 |
| Price to Sales | 1.45 |
| Price to Cash Flow | 16.15 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|